Oncology Imaging

Medical imaging has become integral to cancer care, assessing the stage and location of cancerous tumors. By utilizing powerful imaging modalities including CT, MRI, MRA and PET/CT, oncology imaging radiologists are able to assist referring physicians in the detection and diagnosis of cancer.

Thumbnail

MRI-guided biopsy decisions halve the rate of clinically insignificant prostate cancer diagnoses

“This paper is the message to healthcare authorities around the world to look over recommendations for men."

CT findings linked with pancreatic cancer

CT findings linked to heightened risk of pancreatic cancer recurrence

In 2023, the Society of Abdominal Radiology released its consensus statement regarding follow-up imaging of patients who have had their cancer surgically resected.

Thumbnail

New research argues for MRI in all prostate cancer patients, even those considered low-risk

The study's findings indicate that obtaining a prostate MRI at the time of a patient's initial diagnosis may provide important insight into how cancer will progress over time.

FAPI PET improves staging and clinical management for a significant portion of pancreatic cancers

Fibroblast activation protein inhibitor PET imaging may provide more accurate insight into the spread of pancreatic cancer than more commonly used 18F-FDG PET/CT.

Thumbnail

Reducing prostate cancer treatment dosage alleviates downsides while remaining effective

Reducing certain treatments by around 25% and 50% still achieves promising PSA response rates, but reduces some of the unwanted side effects of therapy, like dry mouth. 

Thumbnail

Researchers score $2M to examine side effects of radiation therapy in prostate cancer patients

The grant will fund a team at the UCLA Health Jonsson Comprehensive Cancer Center working to identify genetic biomarkers capable of predicting RT side effects.

renal cryoablation volumes

How much is too much when it comes to cryoablation volumes in solitary kidneys?

A paper in the Journal of Vascular and Interventional Radiology offers new guidance on how ablation volumes affect renal function in solitary kidneys and highlights ranges that pose the least risk to patients. 

Thumbnail

Fluorinated contrast agents show 'strong potential' for MRI theranostics

Experts have developed a first-of-its-kind fluorinated contrast agent they believe will provide more detailed MR imaging and aid in the treatment of certain cancers. 

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.